Bank of New York Mellon Corp bought a new position in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 152,703 shares of the technology company's stock, valued at approximately $55,706,000. Bank of New York Mellon Corp owned about 0.13% of Celestica at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in Celestica by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company's stock worth $1,423,333,000 after acquiring an additional 73,022 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Celestica by 24.8% in the 4th quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock valued at $1,187,650,000 after purchasing an additional 798,782 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Celestica by 5,806,149.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company's stock valued at $1,081,323,000 after purchasing an additional 3,657,874 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Celestica by 18.6% in the fourth quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company's stock worth $673,471,000 after purchasing an additional 356,797 shares in the last quarter. Finally, Cibc World Market Inc. boosted its holdings in Celestica by 30.6% in the fourth quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company's stock worth $670,279,000 after purchasing an additional 530,535 shares in the last quarter. Institutional investors own 67.38% of the company's stock.
Celestica Stock Performance
Shares of NYSE:CLS opened at $307.40 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The business's fifty day moving average price is $336.01 and its two-hundred day moving average price is $335.80. Celestica, Inc. has a fifty-two week low of $183.66 and a fifty-two week high of $474.02. The stock has a market capitalization of $35.34 billion, a price-to-earnings ratio of 31.95 and a beta of 2.06.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last issued its earnings results on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, beating the consensus estimate of $2.29 by $0.25. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The company had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the previous year, the company earned $1.39 EPS. The firm's revenue for the quarter was up 62.4% compared to the same quarter last year. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, analysts predict that Celestica, Inc. will post 10.15 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of analysts have recently weighed in on CLS shares. Rothschild & Co Redburn initiated coverage on shares of Celestica in a research note on Friday, May 1st. They issued a "buy" rating and a $460.00 price objective for the company. BWS Financial reaffirmed a "buy" rating on shares of Celestica in a research report on Tuesday, July 28th. Citigroup increased their price objective on Celestica from $338.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, April 29th. UBS Group upgraded shares of Celestica from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $410.00 to $430.00 in a research note on Monday. Finally, Weiss Ratings cut Celestica from a "buy (b)" rating to a "buy (b-)" rating in a report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $439.81.
Read Our Latest Analysis on Celestica
Insider Transactions at Celestica
In related news, CFO Mandeep Chawla sold 17,000 shares of the firm's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the sale, the chief financial officer directly owned 82,444 shares of the company's stock, valued at $32,948,744.60. This trade represents a 17.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Robert Mionis sold 98,453 shares of Celestica stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total value of $36,328,172.47. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 356,553 shares of company stock worth $135,238,444. Company insiders own 1.10% of the company's stock.
About Celestica
(
Free Report)
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.